European Meeting on Molecular Diagnostics (EMMD)
- Noordwijk, Huis ter Duin, October 14-16, 2015
- More info
April 27, 2015
> Submission HORIZON2020 proposal
Wednesday 1-3 April 2015
> 2nd Eu-PIC consortium meeting
Acibadem University Istanbul (TUR)
- www.appm2015istanbul.org
- Eu-PIC meeting: April 2, 13:00-18:00
- Hotel: www.silenceistanbul.com
- Organizer: www.evronas.com
Final Scientific Programme – 2nd Eu-PIC Meeting Istanbul
| April 2nd 2015, Thursday | |
| 08:15-08:55 | Registration |
| 08:55-09:15 | Welcome Cengiz Yakıcıer, İstanbul, Türkiye Tanıl Kocagöz, İstanbul, Türkiye |
| 09:15-09:25 | Opening Remarks Candan Hızel, İstabul, Türkiye |
| 09:25-09:45 | The European Pharmacogenetics Implemetation Consortium: Looking Forward to HORIZON2020 Ron HN van Schaik, Rotterdam, The Netherlands |
| 09:45-10:05 | ESPT- The European Research Strategy for Pharmacogenomics and Personalized Medicine Gerard Siest, Nancy, France |
| 10:05-10:30 | Coffee Break |
| 10:30-10:50 | Keynote Lecture Pharmacogenomics – Where does it Fit into Personalised Medicine Munir Pirmohamed, Liverpool, UK |
| 10:50-11:10 | Title Pending Markus Paulmichl, Salzburg, Austria |
| 11:10-11:30 | Pharmacogenetics and Ethnicity in LatinoAmericans Adrián Llerena, Badajoz, Spain |
| 11:30-11:50 | Challenges in the Implementation of an Alzheimer’s Disease Personalized Medicine Strategy Howard Bergman, Montreal, Canada |
| 11:50-12:10 | A High-throughput Real-time PCR Approach to Pharmacogenomics Studies Peter Jacobs, Brussels, Belgium |
| 12:10-12:30 | Pharmacogenetıcs of Drug Induced Liver Injury Ann Daly, Newcastle, UK |
| 12:30-13:30 | Lunch |
| 13:00-18:00 | EU-PIC CLOSED MEETING |
| 13:30-13:50 | Pharmacogenetics: What Do Psychiatrists Need to Know Kemal Arıkan, İstanbul, Türkiye |
| 13:50-14:10 | RNAi-based personalized therapeutic strategies: Are we there yet? Şükrü Tüzmen, Famagusta, North-Cyprus |
| 14:10-14:30 | From a Clinical Point of View: Applications of Pharmacogenetics in Oncology Haluk Onat, İstanbul, Türkiye |
| 14:30-14:50 | Evaluation of SNPs in Various Diseases and Drug Response Mehmet Gündüz, Ankara, Türkiye |
| 14:50-15:10 | Bioinformatics for Personalized Medicine Yeşim Aydın Son, Ankara, Türkiye |
| 15:10-15:40 | Student Presentations Pharmacogenetic and Pharmacoepigenetic Factors for Irinotekan Drug Response in Colon Cancer Treatment Duygu Abbasoğlu, Eskişehir, Türkiye Importance of Multidrug Resistance Gene 1 (MDR 1) in Personalized Cancer Treatment Arsalan Amirfallah, DVM Medical Doctors’ and Students’ Opinion on Euthanasia Bekir Berker Artukoğlu, İstanbul, Türkiye |
| 15:40-16:00 | Coffee Break |
| 16:00-16:20 | Pharmacogenetics of Warfarin: Lessons Learned in Türkiye Oğuz Öztürk, Istanbul, Türkiye |
| 16:20-16:40 | Antioxidant Supplementation on Cancer Risk and Concurrent Use of Antioxidants during Cancer Therapy: An Update Tomris Özben, Antalya, Türkiye |
| 16:40-17:00 | Next Generation Multiplexing Analysis, A True Aid for Researchers That Face a Constantly Changing World Ronald Vos, Ghent, Belgium |
| 17:00-17:20 | The Role of General Practice in Pharmacogenomics Gillian Bartlett, Montréal, Canada |
| 17:20-17:40 | Cell Death-Based Pharmacodynamic Biomarkers for the Prediction of Response to Chemotherapy Engin Ulukaya, Bursa, Türkiye |
| 17:40-18:00 | State of Pharmacogenetic Testing in Türkiye Rıdvan Seçkin Özen, Istanbul, Türkiye |
| 18:00-19:00 | ESPT Closed Meeting |
| April 3rd 2015, Friday | |
| 09:00-09:20 | Horizon Scanning: Genomic Medicine? Maurizio Ferrari, Milan, Italy |
| 09:20-09:40 | Pharmacogenetic Studies of Ultra-Rapid CYP2C6 metabolizers in Southeast of Türkiye Şükrü Aynacıoğlu, Gaziantep, Türkiye |
| 09:40-10:00 | Coffee Break |
| 10:00-10:20 | Commercialization of Pharmacogenomics / Precision Medicine Fareed Kureshy, San Diego, Vista, USA |
| 10:20-10:40 | Pharmacogenomics Approach to 5-Fluorouracil (5-FU)-based Chemotherapy; A Personalized Cancer Management Experience in Dokuz Eylül University, Türkiye Yasemin Baskın, İzmir, Türkiye |
| 10:40-11:00 | Drug-Drug Interactions in Cardiovascular Pharmacotherapeutics Sophie Visvikis-Siest, Nancy, France |
| 11:00-11:20 | Pharmacovigilance and Adverse Drug Reaction (ADR) Prediction Semra Şardaş, Istanbul, Türkiye |
| 11:20-11:40 | Pharmacogenomics and Personalised Medicine of Antidiabetic drugs Vangelis Manolopoulos, Alexandrouplois, Greece |
| 11:40-12:00 | Implementation of a clinical research pharmacogenomics program at an academic medical center; Lessons Learned in Italy Maurizio Simmaco, Roma, Italy |
| 12:00-12:20 | Closing & Discussion |
April 2-3, Istanbul
Dear Colleagues, Dear Friends,
I would like also to take this opportunity to express my heartfelt thanks to each of you, speakers, Eu-PIC members, organizing committee, Scientific/Education committee, organizing secretariat and sponsors for valuable contribution and for agreeing to participate in International Symposium on ADVANCES IN PREDICTIVE & PERSONALIZED MEDICINE” at Acıbadem University in Istanbul. Your valuable contribution and enthusiastic participation made this program a reality. I really believe that your enthusiastic and encouraging participation in this program help accelerate clinical uptake and application of Predictive & Personalized Medicine into mainstream healthcare in this this post-genomics era.
Many thanks to Acıbadem University to have welcomed this program at sumptuous campus in Istanbul. Once again, I would also like to extend my sincere thanks to Prof. Ron HN van Schaik for his very precious and very painstaking help, for his constant encouragement to the state of the art this program. Looking forward to seeing you again in the near future Türkiye.
My kindest personal regards to all of you, On behalf of the organizing committee
Candan HIZEL, PhD; Program Co-Chair
Ron van Schaik, PhD, Eu-PIC PI
(Link to: Pictures 1st Eu-PIC meeting Rotterdam….)
Thursday February 26
1st draft workpackages
Descriptives, deliverables, milestones
DEADLINE: WEDNESDAY FEBRUARY 18
Curriculum Vitae’s!
Tuesday 10-11 February 2015
First Eu-PIC consortium meeting
Erasmus MC Rotterdam (NL)
Monday 27 January 2015
Decision Stage 1 proposals